Alan Grujic - Mar 7, 2023 Form 3 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director
Signature: /s/ Alan Grujic
Stock symbol: GTHP
Transactions as of: Mar 7, 2023
Transactions value $: $0
Form type: 3
Date filed: 6/20/2023, 02:50 PM
Next filing: Sep 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	GTHP	Common Stock						1.39M	Mar 7, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GTHP	Series E Preferred Stock							Mar 7, 2023	Common Stock	50	$4,000.00	Direct	F2
holding	GTHP	Warrants to Purchase Common Stock							Mar 7, 2023	Common Stock	500K	$0.50	Direct
holding	GTHP	Warrants to Purchase Common Stock							Mar 7, 2023	Common Stock	500K	$0.65	Direct
holding	GTHP	Warrants to Purchase Common Stock							Mar 7, 2023	Common stock	800K	$0.50	Direct
holding	GTHP	Stock Option (right to buy)							Mar 7, 2023	Common Stock	100K	$0.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-fourth of the shares subject to the award vested on March 7, 2023; the remaining shares will vest monthly, starting 90 days from the grant date, subject to the reporting person's continued service on each such date, until the award is fully vested on March 7, 2026.
F2	These securities consist of Series E Convertible Preferred Stock ("Series E Preferred") of the Issuer that are presently convertible on a 1-for-4,000 basis into Common Stock without payment or further consideration. The Series E Preferred shares are convertible at any time for a period of five years after issuance. The Series E Preferred have no expiration date.